Is Cyclopentasiloxane safe for babies and kids?
Context-dependent for kids(Babies-specific data is limited; this page draws from human pregnant context.) Pregnancy alters the metabolism and distribution of Cyclopentasiloxane, potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.
What is cyclopentasiloxane?
The IUPAC name is decamethylcyclopentasiloxane.
Also known as: decamethylcyclopentasiloxane, D5, DC 245.
- IUPAC name
- decamethylcyclopentasiloxane
- CAS number
- 541-02-6
- Molecular formula
- C10H30O5Si5
- Molecular weight
- 370.77 g/mol
- SMILES
- CCN(CC)CC(=O)OC1=C(C=C(C=C1C)C)C
- PubChem CID
- 16211
Risk for babies
Context-dependentPregnancy alters the metabolism and distribution of Cyclopentasiloxane, potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.
No specific reproductive toxicity data identified, but pregnancy-specific safety data is limited for most chemicals. Precautionary minimization of exposure is recommended.
Risk for pregnant and nursing people
Context-dependentPregnancy alters the metabolism and distribution of Cyclopentasiloxane, potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.
No specific reproductive toxicity data identified, but pregnancy-specific safety data is limited for most chemicals. Precautionary minimization of exposure is recommended.
Regulatory consensus
2 regulatory and scientific bodies have classified Cyclopentasiloxane. The classifications differ — that's the data.
| Agency | Year | Classification | Notes |
|---|---|---|---|
| EU_Cosmetics_Regulation | — | — | Annex XVII restriction: ≤0.1% in wash-off products only; banned in leave-on cosmetics (rinse-off formulations); environmental concern due to persistence |
| FDA_OTC | — | — | Approved for cosmetic use in USA; no concentration restriction |
Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.
Where kids encounter cyclopentasiloxane
- primer
- foundation
- leave_on_sunscreen
- hair_care
Safer alternatives
Lower-risk approaches that achieve a similar outcome to Cyclopentasiloxane:
-
Plant-derived oils with established safety profiles (jojoba, squalane, shea butter)
Trade-offs: Consumer preference for 'natural' label; many natural fragrance compounds are potent allergens (limonene, linalool, eugenol); 'natural' ≠ 'safe'; often more expensive than synthetic equivalents.Relative cost: 2-5× conventional
-
Ceramide-based formulations (biomimetic skin barrier repair)
Trade-offs: Alternative emollient; skin feel, spreadability, and occlusion properties differ; comedogenicity should be assessed for facial use; stability in final formulation needs verification.Relative cost: 1.2-2×
-
Glycerin-based humectant systems as partial replacement
Trade-offs: Direct chemical substitution requires verification that the replacement does not introduce new hazards (regrettable substitution). Conduct full hazard assessment of proposed alternative before adoption.Relative cost: 1.2-2×
Frequently asked questions
What products contain cyclopentasiloxane?
Cyclopentasiloxane appears in: primer; foundation; leave on sunscreen.
See Cyclopentasiloxane in the baby app
Look up products containing cyclopentasiloxane, compare to alternatives, and explore the full data record.
Open in baby View raw API dataSources (2)
- PubChem Compound CID 16211 — database
- ATSDR Toxicological Profile — CAS 541-02-6 — reference
Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →